DelveInsight has launched a new report on “Attention-deficit/hyperactivity disorder (ADHD) Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Attention-deficit/hyperactivity disorder (ADHD) Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Attention-deficit/hyperactivity disorder (ADHD), historical and forecasted epidemiology as well as the Attention-deficit/hyperactivity disorder (ADHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the Key facts:
Request for Free Sample Report: https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market
Report Highlights:
Attention-deficit/hyperactivity disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. ADHD is a group of behaviors and is also called as attention deficit disorder (ADD). ADHD is a behavioral disorder that includes symptoms such as inattentiveness, hyperactivity, and impulsiveness.
Symptoms of ADHD tend to be noticed at an early age and may become more noticeable when a child’s circumstances change, such as when they start school. Most cases are diagnosed when children are 6 to 12 years old. The symptoms of ADHD usually improve with age, but many adults who were diagnosed with the condition at a young age continue to experience problems. People with ADHD may also have additional problems, such as sleep and anxiety disorders.
According to a study conducted by Guifeng et al. titled “Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder among US Children and Adolescents, 1997–2016,” published in 2018, estimated the prevalence of diagnosed attention-deficit/hyperactivity disorder increased significantly between 1997 and 2016. It has also been observed that the prevalence in children varied between 7.7% and 13.5%.
Subtype-specific diagnosed prevalence of ADHD is divided into various types such as Inattentive; Hyperactive/impulsive; combined. As per DelveInsight estimates, the diagnosed prevalence of combined type of ADHD was found to be highest in the United States.
Companies covered
And many others
Drugs covered
Table of Contents:
1. Key Insights
2. Executive Summary of Attention-deficit/hyperactivity disorder (ADHD)
3. Competitive Intelligence Analysis for Attention-deficit/hyperactivity disorder (ADHD)
4. Attention-deficit/hyperactivity disorder (ADHD): Market Overview at a Glance
5. Attention-deficit/hyperactivity disorder (ADHD): Disease Background and Overview
6. Patient Journey
7. Attention-deficit/hyperactivity disorder (ADHD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Attention-deficit/hyperactivity disorder (ADHD) Treatment
11. Marketed Products
12. Emerging Therapies
13. Attention-deficit/hyperactivity disorder (ADHD): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Attention-deficit/hyperactivity disorder (ADHD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Detailed TOC: https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/